Partner Fund Management »

Metagenomi shares owned by Partner Fund Management

Quarter-by-quarter ownership of Metagenomi (MGX) shares owned by Partner Fund Management from 13F filings

Historical chart of Partner Fund Management investment in Metagenomi

Tip: Access up to 7 years of quarterly data

All positions including Metagenomi held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Metagenomi by Partner Fund Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.2M 1.3M 4.08
2024-03-31 $13M 1.3M 10.55

More positions owned by Partner Fund Management

Eli Lilly & Co. (LLY)
Cytokinetics Com New (CYTK)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tenet Healthcare Corp Com New (THC)
Merck & Co (MRK)
Vertex Pharmaceuticals Incorporated (VRTX)
Abbvie (ABBV)
Edwards Lifesciences (EW)
UnitedHealth Call Option (UNH)
Intuitive Surgical Com New (ISRG)
McKesson Corporation (MCK)
Spdr Ser Tr S&p Biotech Call Option (XBI)
Humana (HUM)
Hca Holdings (HCA)
Centene Corporation (CNC)

View all positions for Partner Fund Management

Top funds holding Metagenomi

Novo A/S
RA Capital Management
Farallon Capital Management
Partner Fund Management
Hillhouse Capital Advisors
Citadel Advisors
Eventide Asset Management
Deep Track Capital
BlackRock
Millennium Management
Artal Group
Frazier Life Sciences Management
Vanguard Group
Marshall Wace
Geode Capital Management

View all funds holding Metagenomi